1. Introduction
Infertility, defined as the “failure to establish a clinical pregnancy after 12 months of unprotected intercourse” [
1], concerns up to 12% of couples worldwide [
2]. It is a condition in which the functionality of the reproductive system of an individual is impaired, which may have numerous causes. These include certain pathologies of the genital tract, past or ongoing general diseases, genetic predispositions as well as an unhealthy lifestyle [
3,
4,
5,
6]. Moreover, the origin of 15 to 30% of infertility cases remains unclear [
7]. Furthermore, subfertility has numerous comorbidities and may lead to mental health disorders and psychological distress [
8,
9,
10]. Partners suffering from reduced fecundity can turn to assisted reproductive technologies (ARTs) that were developed to facilitate conception and early embryo development, providing a potential solution to achieve pregnancy and the birth of a healthy offspring. Owing to the emergence and continuing amelioration of ARTs, more than 10 million babies have been born worldwide since 1978 [
11]. In humans, an in vitro fertilization (IVF) cycle involves hormonal stimulation of ovaries and subsequent retrieval of mature oocytes or in vitro maturation (IVM) of oocytes, in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), in vitro culture (IVC) of preimplantation embryos, and embryo transfer (ET) to the uterus. Despite the early unfolding of research which led to and shaped the current assisted reproductive procedures [
12], the success rates of in vitro embryo production (IVP) are considered suboptimal and vary between species. In human IVP, approximately 50% of in vitro fertilized oocytes reach the blastocyst stage [
13]. In animal IVP, better results can be achieved when the in vivo matured ovum is used as compared to IVM eggs. In mice and cattle, around 80-90% [
14] and 55% [
15] of zygotes can grow into blastocysts from matured oocytes collected from the uterine tubes, respectively. The results differ significantly when oocytes undergo IVM, decreasing the developmental rates to 38% [
16] and 20-40% [
17] in murine and bovine IVP, respectively.
The mouse is the most extensively used animal model in studies on mammalian reproduction. However, the existing genetic and morphological differences between mouse and human embryos entail the use of other mammalian species as models for study purposes as well as validation of novel methods in ARTs [
18]. Cattle may provide a suitable model as the early embryo development in vitro as well as the size of blastocysts more closely resemble the human species, with embryonic size being an important characteristic for microfluidic studies.
Figure 1 presents similarities between the timing of subsequent cell division cycles (cleavage) from the point of fertilization until the blastocyst formation in human and bovine species. A bovine in vitro produced expanded blastocyst (at day 7 or 8 of culture) has a diameter of approximately 194 µm [
19]. A human expanded blastocyst (at day 5) created using a donor oocyte which underwent in vitro fertilization and culture has a diameter of around 194 µm [
20]. For comparison, a murine expanded blastocyst (collected from a female mouse at day 3.5 post mating) has a diameter of 104 µm [
21]. Embryonic genome activation (EGA) happens at different developmental stages and varies among species [
22]. In humans, the EGA occurs at 4- to 8-cell stage [
22,
23,
24,
25], however, earlier initiation of embryonic genome transcription was suggested and reported recently, indicating it is triggered after fertilization [
25]. In cattle, the EGA has been reported to occur at 8- to 16-cell stage [
24,
26], however, state-of-the-art gene profiling of 1-cell zygotes may lead to similar observations as in humans. In vitro production of bovine embryos has played a significant role in the establishment of a genetic pool from superior individuals in beef and dairy cattle. Since 2016, a switch towards the use of IVP embryos instead of multiple ovulation embryo transfer among cattle breeders can be observed [
17]. Bovine IVP plays an important role in the studies on reproduction which led to the advancements in mammalian IVP. Moreover, it gives insight into the effects of environmental factors such as heat stress on early gestation. The availability of the inexpensive abattoir-derived material contributed to the increasing interest in bovine IVP [
26,
27,
28]. In cattle, the conditions of IVC affect the timing of embryo development and the size of the resulting blastocysts [
29]. The in vivo culture of IVP zygotes in the oviducts of other mammals or the homologous bovine resulted in better quality blastocysts, while the IVC of in vivo derived zygotes yielded lower quality blastocysts [
17,
30]. Culturing bovine embryos in group instead of as individual embryos [
31] and addition of extracellular vesicles (EVs) collected from the female’s reproductive tract to the culture medium [
32] were found to alleviate the detrimental effects related to the lack of the embryo-maternal crosstalk in in vitro settings. Therefore, it becomes clear that the inferior development of lab-grown mammalian embryos can be linked to the absence of the oviduct, as well as suboptimal culture conditions [
26,
30]. Despite various attempts to imitate the surroundings of a developing embryo
in vivo, a culture system that would mimic such sophisticated, dynamic microenvironment [
33], is still lacking.
Microfluidics encompasses the study of the behavior and methods for manipulation of liquids in microstructured devices as well as their fabrication [
34]. With its advancement, novel solutions for the on-chip manipulation of gametes and embryos were proposed and extensively reviewed in recent years [
35,
36,
37,
38]. Furthermore, microdevices which utilize electric phenomena, such as dielectrophoresis (DEP) and electrowetting on dielectric (EWOD) are being progressively recognized as promising tools in mammalian ARTs [
41]. EWOD, known as digital microfluidics (DMF), allows for the automation of laboratory workflows and its field of application is continuously expanding [
42,
43]. The technology employs applied electric fields [
44] to manipulate pico- to micro-liter (10
-12 – 10
-6 L) droplets in a rapid manner on an array of insulated electrodes on the chip [
45,
46,
47]. Plentiful examples of EWOD based microdevices created for chemistry and life sciences exist [
48,
49,
50,
51,
52,
53,
54]. A novel direction for EWOD in ARTs was proposed recently, allowing for the analysis of spent culture medium from a single human embryo with no interference to the culture protocol, which is unachievable using standard techniques [
55]. However, the application of digital microfluidics in ARTs is in its infancy and thus far only murine embryos were successfully manipulated and cultured on a chip [
56]. The novelty of advanced technologies necessitates validation in various animal studies which could likewise benefit from their commercial application in the near future. Here, we demonstrate the development of the first digital microfluidic device suitable for the in vitro manipulation of bovine embryos. The process of fabrication and the first application in bovine IVP are presented. Encountered challenges and future directions for chip development are identified and discussed.
Figure 1.
Timing of the early development of human (blue color) and bovine (red color) embryos from fertilization to the blastocyst stage. (1) Spermatozoon penetrates the zona pellucida of the oocyte: fertilization. (2) Zygote after the 1st cell division (2-cell). (3) Embryo after the 2nd cell cycle (4-cell). (4) Embryo after the 3rd cell cycle (8-cell). (5) Morula, embryo at 16- to 32-cell stage. (6) An early blastocyst: the inner cell mass (embryo proper) represented by the pink clustered cells will differentiate into structures that will give rise to a fetus. Trophoblast surrounding the blastocyst cavity (depicted as red cells) will develop into the placenta. Stages at which embryonic genome activation (EGA) occurs in both species are shown. The figure was based on the information provided in articles [
23,
24,
25,
29,
39,
40].
Figure 1.
Timing of the early development of human (blue color) and bovine (red color) embryos from fertilization to the blastocyst stage. (1) Spermatozoon penetrates the zona pellucida of the oocyte: fertilization. (2) Zygote after the 1st cell division (2-cell). (3) Embryo after the 2nd cell cycle (4-cell). (4) Embryo after the 3rd cell cycle (8-cell). (5) Morula, embryo at 16- to 32-cell stage. (6) An early blastocyst: the inner cell mass (embryo proper) represented by the pink clustered cells will differentiate into structures that will give rise to a fetus. Trophoblast surrounding the blastocyst cavity (depicted as red cells) will develop into the placenta. Stages at which embryonic genome activation (EGA) occurs in both species are shown. The figure was based on the information provided in articles [
23,
24,
25,
29,
39,
40].
5. Conclusions
Methods in assisted reproduction, particularly the in vitro procedures like maturation and fertilization of gametes, and subsequent embryo culture, can benefit markedly from (digital) microfluidics. Such state-of-the-art technologies will drive the long-awaited transition towards the development of automated and biomimetic cell culture (micro)systems. Microfluidics allows for a better approximation and monitoring of the conditions of the cellular microenvironment in vivo. Although the potential of the use of (D)MF in ARTs seems eminently promising, due to the novelty of this research field, more studies need to be performed to evaluate the mode of application as well as its effects on the development of mammalian embryos. In this article, the results of the static embryo culture in vitro along with the effects of the first application of the developed EWOD chip are presented. Interestingly, decreasing the volume of the culture medium did not affect blastocyst rates in droplet embryo culture, suggesting a promising direction for the development of more biomimetic IVP microdevices in ARTs. Methods of fabrication of the digital microfluidic devices developed for the in vitro culture of bovine embryos are described. Although the desired result, i.e., the on-chip embryo culture until the blastocyst stage, was not yet achieved, two modes of successful droplet actuation are demonstrated: droplet transport and medium supply during IVC. Furthermore, early bovine embryos seem to survive the applied electric fields. Lastly, the encountered challenges related to the limitations of the prototype, along with the direction for its future optimization are indicated. The presented prototype utilizes EWOD and can be easily adapted to allow for on-chip operations such as droplet dispensing and splitting. This can be applied for the in vitro culture of diverse types of cells, requiring both frequent as well as occasional stimulation.
Author Contributions
Conceptualization, A.K., A.V.S., K.S., S.V.V., J.V. and R.V.; methodology, A.K.; validation, A.K.; formal analysis, O.B.P. and A.K.; investigation, A.K.; resources, A.K., J.V., A.V.S. and S.V.V.; data curation, O.B.P., A.K.; writing—original draft preparation, A.K.; writing—review and editing, A.K., A.V.S., K.S., S.V.V., R.V., O.B.P., J.V.; visualization, A.K., O.B.P.; supervision, A.V.S., J.V., S.V.V.; project administration, A.K., A.V.S., K.S., S.V.V., R.V., J.V.; funding acquisition, A.V.S., J.V., E.V.A. All authors have read and agreed to the published version of the manuscript.